| ||
| Cancer drug shows promise for treating scleroderma EurekAlert (press release) A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, ... See all stories on this topic » | ||
| Roses & Raspberries Battle Creek Enquirer Jean Krohn, project coordinator • Red roses to my doctors, Debra Beard MD and surgeon Tammy Gleason, for continuing to search until they found my Stage 1 lung cancer. Because of them I am now cancer-free. Also roses to the staff at Battle Creek Health ... See all stories on this topic » |
| ||
| ALCMI launches new CASTLE study to treat lung cancer ... The Addario Lung Cancer Medical Institute today announced the enrollment of the initial subjects into its inaugural clinical trial known as CASTLE, ... organizedwisdom.com/alcmi-launches-new-castle.../med | ||
| Cetuximab, Cisplatin, Docetaxel, Radiation Therapy, and Surgery in ... Cetuximab, Cisplatin, Docetaxel, Radiation Therapy, and Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer That Can Be Removed by ... lungcancertreatment.org/cetuximab-cisplatin-docetaxel-radiati... | ||
| Combo of Arthritis Drug and Experimental Cancer Drug Useful for ... MedIndia | A drug that is commonly used to treat arthritis, ... Analytical Tool - Lung Cancer is a premium combo product of "Competitive Outlook on Lung ... www.bioportfolio.com/.../Combo-Of-Arthritis-Drug-And-Exp... |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment